Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ratnadeep Basu

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Journal of the American Heart Association|May 2, 2019
PI3Kα Pathway Inhibition With Doxorubicin Treatment Results in Distinct Biventricular Atrophy and Remodeling With Right Ventricular DysfunctionBrent A McLean, Vaibhav B Patel, Pavel Zhabyeyev, et al.
Circulation. Heart Failure|October 8, 2009
Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarctionZamaneh Kassiri, Jiuchang Zhong, Danny Guo, et al.
American Journal of Physiology. Heart and Circulatory Physiology|August 3, 2010
Early activation of matrix metalloproteinases underlies the exacerbated systolic and diastolic dysfunction in mice lacking TIMP3 following myocardial infarctionVijay Kandalam, Ratnadeep Basu, Thomas Abraham, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|March 11, 2016
Differential impact of mechanical unloading on structural and nonstructural components of the extracellular matrix in advanced human heart failureSiva S V P Sakamuri, Abhijit Takawale, Ratnadeep Basu, et al.
Hypertension (Dallas, Tex. : 1979)|April 18, 2012
Cardioprotective effects mediated by angiotensin II type 1 receptor blockade and enhancing angiotensin 1-7 in experimental heart failure in angiotensin-converting enzyme 2-null miceVaibhav B Patel, Sreedhar Bodiga, Dong Fan, et al.
Journal of Molecular Medicine (Berlin, Germany)|April 15, 2014
Heterozygote loss of ACE2 is sufficient to increase the susceptibility to heart diseaseWang Wang, Vaibhav B Patel, Nirmal Parajuli, et al.
Journal of Molecular Medicine (Berlin, Germany)|April 16, 2015
Antagonism of angiotensin 1-7 prevents the therapeutic effects of recombinant human ACE2Vaibhav B Patel, Abhijit Takawale, Tharmarajan Ramprasath, et al.
Journal of Molecular and Cellular Cardiology|December 17, 2013
Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: a positive feedback mechanism in the RASVaibhav B Patel, Nicola Clarke, Zuocheng Wang, et al.
Cardiovascular Research|January 26, 2015
PI3Kα is essential for the recovery from Cre/tamoxifen cardiotoxicity and in myocardial insulin signalling but is not required for normal myocardial contractility in the adult heartBrent A McLean, Pavel Zhabyeyev, Vaibhav B Patel, et al.
Hypertension (Dallas, Tex. : 1979)|August 24, 2016
A Disintegrin and Metalloprotease-17 Regulates Pressure Overload-Induced Myocardial Hypertrophy and Dysfunction Through Proteolytic Processing of Integrin β1Dong Fan, Abhijit Takawale, Mengcheng Shen, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Journal of the American Heart Association|May 2, 2019
PI3Kα Pathway Inhibition With Doxorubicin Treatment Results in Distinct Biventricular Atrophy and Remodeling With Right Ventricular DysfunctionBrent A McLean, Vaibhav B Patel, Pavel Zhabyeyev, et al.
Circulation. Heart Failure|October 8, 2009
Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarctionZamaneh Kassiri, Jiuchang Zhong, Danny Guo, et al.
American Journal of Physiology. Heart and Circulatory Physiology|August 3, 2010
Early activation of matrix metalloproteinases underlies the exacerbated systolic and diastolic dysfunction in mice lacking TIMP3 following myocardial infarctionVijay Kandalam, Ratnadeep Basu, Thomas Abraham, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|March 11, 2016
Differential impact of mechanical unloading on structural and nonstructural components of the extracellular matrix in advanced human heart failureSiva S V P Sakamuri, Abhijit Takawale, Ratnadeep Basu, et al.
Hypertension (Dallas, Tex. : 1979)|April 18, 2012
Cardioprotective effects mediated by angiotensin II type 1 receptor blockade and enhancing angiotensin 1-7 in experimental heart failure in angiotensin-converting enzyme 2-null miceVaibhav B Patel, Sreedhar Bodiga, Dong Fan, et al.
Journal of Molecular Medicine (Berlin, Germany)|April 15, 2014
Heterozygote loss of ACE2 is sufficient to increase the susceptibility to heart diseaseWang Wang, Vaibhav B Patel, Nirmal Parajuli, et al.
Journal of Molecular Medicine (Berlin, Germany)|April 16, 2015
Antagonism of angiotensin 1-7 prevents the therapeutic effects of recombinant human ACE2Vaibhav B Patel, Abhijit Takawale, Tharmarajan Ramprasath, et al.
Journal of Molecular and Cellular Cardiology|December 17, 2013
Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: a positive feedback mechanism in the RASVaibhav B Patel, Nicola Clarke, Zuocheng Wang, et al.
Cardiovascular Research|January 26, 2015
PI3Kα is essential for the recovery from Cre/tamoxifen cardiotoxicity and in myocardial insulin signalling but is not required for normal myocardial contractility in the adult heartBrent A McLean, Pavel Zhabyeyev, Vaibhav B Patel, et al.
Hypertension (Dallas, Tex. : 1979)|August 24, 2016
A Disintegrin and Metalloprotease-17 Regulates Pressure Overload-Induced Myocardial Hypertrophy and Dysfunction Through Proteolytic Processing of Integrin β1Dong Fan, Abhijit Takawale, Mengcheng Shen, et al.
Pageof 5